Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Mauri

Showing results (31-40 of 335) with videos related to

Pageof 34
Sort By:
Circulation|June 22, 2005
Late loss in lumen diameter and binary restenosis for drug-eluting stent comparisonLaura Mauri, E John Orav, Richard E Kuntz
Circulation|February 7, 2007
Receiver-operating characteristic analysis for evaluating diagnostic tests and predictive modelsKelly H Zou, A James O'Malley, Laura Mauri
The New England Journal of Medicine|April 2, 2015
Duration of dual antiplatelet therapy after drug-eluting stentsLaura Mauri, Robert W Yeh, Dean J Kereiakes
Glycobiology|September 20, 2006
Gangliosides as components of lipid membrane domainsSandro Sonnino, Laura Mauri, Vanna Chigorno, et al.
Circulation|October 17, 2007
Letter by Kereiakes et al regarding article, "Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern"Dean J Kereiakes, Laura Mauri, Richard E Kuntz
JACC. Cardiovascular Interventions|July 22, 2017
Reply: Duration of the Double Antiplatelet Therapy in Patients With Coronary and Peripheral Arterial Disease: The Key Might Be in the Type of DrugEric A Secemsky, Robert W Yeh, Laura Mauri, et al.
Journal of the American College of Cardiology|February 21, 2006
Drug-eluting stenting for unprotected left main coronary artery disease: are we ready to replace bypass surgery?Donald S Baim, Laura Mauri, Donald C Cutlip
Lancet (London, England)|August 24, 2017
Update on antithrombotic therapy after percutaneous coronary revascularisationThomas Cuisset, Freek W A Verheugt, Laura Mauri
European Heart Journal|March 22, 2015
Close encounters with errors of the second kind: evaluating risks and benefits of long-term dual antiplatelet therapyRobert W Yeh, David J Cohen, Laura Mauri
Journal of the American College of Cardiology|May 10, 2008
Balancing the risks of restenosis and stent thrombosis in bare-metal versus drug-eluting stents: results of a decision analytic modelPallav Garg, David J Cohen, Thomas Gaziano, et al.
Pageof 34

Showing results (31-40 of 335) with videos related to

Sort By:
Pageof 34
Circulation|June 22, 2005
Late loss in lumen diameter and binary restenosis for drug-eluting stent comparisonLaura Mauri, E John Orav, Richard E Kuntz
Circulation|February 7, 2007
Receiver-operating characteristic analysis for evaluating diagnostic tests and predictive modelsKelly H Zou, A James O'Malley, Laura Mauri
The New England Journal of Medicine|April 2, 2015
Duration of dual antiplatelet therapy after drug-eluting stentsLaura Mauri, Robert W Yeh, Dean J Kereiakes
Glycobiology|September 20, 2006
Gangliosides as components of lipid membrane domainsSandro Sonnino, Laura Mauri, Vanna Chigorno, et al.
Circulation|October 17, 2007
Letter by Kereiakes et al regarding article, "Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern"Dean J Kereiakes, Laura Mauri, Richard E Kuntz
JACC. Cardiovascular Interventions|July 22, 2017
Reply: Duration of the Double Antiplatelet Therapy in Patients With Coronary and Peripheral Arterial Disease: The Key Might Be in the Type of DrugEric A Secemsky, Robert W Yeh, Laura Mauri, et al.
Journal of the American College of Cardiology|February 21, 2006
Drug-eluting stenting for unprotected left main coronary artery disease: are we ready to replace bypass surgery?Donald S Baim, Laura Mauri, Donald C Cutlip
Lancet (London, England)|August 24, 2017
Update on antithrombotic therapy after percutaneous coronary revascularisationThomas Cuisset, Freek W A Verheugt, Laura Mauri
European Heart Journal|March 22, 2015
Close encounters with errors of the second kind: evaluating risks and benefits of long-term dual antiplatelet therapyRobert W Yeh, David J Cohen, Laura Mauri
Journal of the American College of Cardiology|May 10, 2008
Balancing the risks of restenosis and stent thrombosis in bare-metal versus drug-eluting stents: results of a decision analytic modelPallav Garg, David J Cohen, Thomas Gaziano, et al.
Pageof 34